GlassScriptPhysician profile
Laura Corene Reviere
NPI 1558769901
$2,710.90
in general payments reported to CMS, 2019-2025
20 companies · $470 in 2025
The $470 reported for 2025 was more than what 85% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $554 · 2022: $501 · 2023: $594 · 2024: $593 · 2025: $470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,466 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,466.24 |
| Education | $190.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $661.82 | 2023-2025 | Veozah |
| Abbvie INC. | $442.85 | 2021-2024 | |
| Mayne Pharma Commercial LLC | $379.80 | 2021-2025 | |
| Exeltis, USA INC. | $291.86 | 2021-2025 | Slynd, Twirla |
| Bayer Healthcare Pharmaceuticals INC. | $178.61 | 2021-2023 | |
| Novo Nordisk INC | $127.45 | 2024-2025 | Wegovy |
| Millicent US INC | $106.86 | 2022-2025 | Intrarosa, Femlyv |
| Agile Therapeutics, INC. | $84.88 | 2021-2022 | |
| Organon LLC | $80.91 | 2021-2022 | |
| Channel Medsystems, INC. | $73.75 | 2022-2023 | |
| Mylan Pharmaceuticals INC. | $55.61 | 2021-2022 | |
| Currax Pharmaceuticals LLC | $44.36 | 2024 | Contrave |
| Evofem Biosciences, INC. | $37.27 | 2021 | |
| Exact Sciences Corporation | $31.38 | 2023 | Cologuard Collection Kit |
| Avion Pharmaceuticals | $27.56 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $18.89 | 2021 | |
| Tris Pharma INC | $18.23 | 2025 | Dyanavel Xr |
| Shield Therapeutics INC | $16.67 | 2023 | Accrufer |
| Hologic Sales and Service, LLC | $16.31 | 2023 | Omni Hysteroscope |
| Coopersurgical, INC. | $15.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Reviere listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.